Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.000
+0.060 (3.09%)
At close: Apr 7, 2026, 4:00 PM EDT
2.020
+0.020 (1.00%)
After-hours: Apr 7, 2026, 7:54 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Lipocine in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $15 | Strong Buy | Maintains | $7 → $15 | +650.00% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +250.00% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +300.00% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +300.00% | Jun 27, 2025 |
Financial Forecast
Revenue This Year
637.50K
from 1.98M
Decreased by -67.75%
Revenue Next Year
1.22M
from 637.50K
Increased by 92.00%
EPS This Year
-1.85
from -1.77
EPS Next Year
-1.07
from -1.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 892,500 | 1.3M | |||
| Avg | 637,500 | 1.2M | |||
| Low | 392,000 | 1.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -54.8% | 97.6% | |||
| Avg | -67.7% | 92.0% | |||
| Low | -80.2% | 84.5% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.42 | -1.10 |
| Avg | -1.85 | -1.07 |
| Low | -2.22 | -1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.